NUTRITION INTERVENTION TRIALS IN LINXIAN, CHINA

Information

• Research Project
• 3626425

• ApplicationId

  3626425

• Core Project Number

  N01CP005634

• Full Project Number

  N01CP005634-002

• Serial Number

  5634

• FOA Number

• Sub Project Id

• Project Start Date

  9/28/1990 - 34 years ago

• Project End Date

  9/27/1991 - 33 years ago

• Program Officer Name

• Budget Start Date

  12/1/1990 - 33 years ago

• Budget End Date

  9/27/1991 - 33 years ago

• Fiscal Year

  1991

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• CHINESE ACADEMY OF MEDICAL SCIENCES

The objectives of this project are to continue two randomized controlled intervention trials currently underway in Linxian, a country in north central China with one of the world's highest rate of esophageal cancer. This involves the distribution of NCI-supplied vitamin/mineral pills to 3400 persons with esophageal dysplasia, and to 30,000 in the general population of this high-risk area. All deaths and cancer occurrences among the study populations will be recorded so that mortality and cancer incidence rates between those receiving active pills vs placebo can be contrasted to test the effectiveness of the nutrient supplementation in reducing cancer risk. During this contract year, pill distribution will come to a close, changes in cytologic status of dysplasia patients will be assessed, and treatment group differences in endpoints will be calculated.

IC Name

• Activity

  N01

• Administering IC

  CP

• Application Type

  3

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

• Sub Project Total Cost

• ARRA Funded

• CFDA Code

• Ed Inst. Type

• Funding ICs

• Funding Mechanism

• Study Section

• Study Section Name

• Organization Name

  CHINESE ACADEMY OF MEDICAL SCIENCES

• Organization Department

• Organization DUNS

• Organization City

  BEIJING

• Organization State

• Organization Country

  CHINA

• Organization Zip Code

• Organization District

  CHINA